Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma
Condition(s):Recurrent Neuroblastoma; NeuroblastomaLast Updated:March 31, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Recurrent Neuroblastoma; NeuroblastomaLast Updated:March 31, 2022Terminated
Condition(s):Recurrent Neuroblastoma; NeuroblastomaLast Updated:March 21, 2022No longer available
Condition(s):Recurrent or Refractory Solid Tumors; Ewing Sarcoma; Rhabdomyosarcoma; Neuroblastoma; OsteosarcomaLast Updated:March 31, 2022Unknown status
Condition(s):Solid TumorLast Updated:March 31, 2022Terminated
Condition(s):Ovarian Cancer; Cancer of Ovary; Cancer of the Ovary; Ovary Neoplasms; Primary Peritoneal CarcinomaLast Updated:August 27, 2020Terminated
Condition(s):Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Non-Hodgkin’s LymphomaLast Updated:March 31, 2022Terminated
Condition(s):Cancer of PancreasLast Updated:September 6, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.